Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference
28 August 2023 - 10:00PM
Esperion (NASDAQ: ESPR) today announced its participation in the
H.C. Wainwright 25th Annual Global Investment Conference. Sheldon
Koenig, President and Chief Executive Officer, will participate in
a corporate presentation on Monday, September 11, 2023 at 3:00 PM
ET. The Esperion management team will also host investor meetings
that same day.
To register for the live webcast, follow this link.
A live audio webcast can be accessed on the investor and media
section of the Esperion website at investor.esperion.com. Access to
the webcast replay will be available approximately two hours after
completion of the call and will be archived on the Company's
website for approximately 90 days.
Esperion TherapeuticsAt Esperion, we discover,
develop, and commercialize innovative medicines to help improve
outcomes for patients with or at risk for cardiovascular and
cardiometabolic diseases. The status quo is not meeting the health
needs of millions of people with high cholesterol – that is why our
team of passionate industry leaders is breaking through the
barriers that prevent patients from reaching their goals. Providers
are moving toward reducing LDL-cholesterol levels as low as
possible, as soon as possible; we provide the next steps to help
get patients there. Because when it comes to high cholesterol,
getting to goal is not optional. It is our life’s work. For more
information, visit esperion.com and esperionscience.com and follow
us on Twitter at twitter.com/EsperionInc.
Esperion Contact Information: Investors:
Alexis Callahaninvestorelations@esperion.com(406)
539-1762 Media: Tiffany Aldrich
corporateteam@esperion.com(616) 443-8438
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Apr 2024 to May 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From May 2023 to May 2024